Crossmark

Subcutaneous Versus Combined Subcutaneous and Intramuscular Botulinum Toxin for Androgenetic Alopecia: A Randomized Clinical Trial

Crossref DOI link: https://doi.org/10.1016/j.ad.2025.01.012

Published Print: 2025-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Lima-Galindo, A.A.

Ocampo-Garza, S.S.

Ocampo-Candiani, J.

Tosti, A.

Sarahi Guerra-Garza, A.

Ocampo-Garza, J.
License Information

Text and Data Mining valid from 2025-10-01

Text and Data Mining valid from 2025-10-01

Version of Record valid from 2025-05-24
More Information

This article is maintained by: Elsevier

Article Title: Subcutaneous Versus Combined Subcutaneous and Intramuscular Botulinum Toxin for Androgenetic Alopecia: A Randomized Clinical Trial

Journal Title: Actas Dermo-Sifiliográficas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ad.2025.01.012

Content Type: article

Copyright: © 2025 AEDV. Published by Elsevier España, S.L.U.